To investigate whether a principal neutralization epitope exists in hypervariable region 1 (HVR1) within the putative envelope of hepatitis C virus (HCV), we generated a hyperimmune rabbit serum against a synthetic peptide corresponding to HVR1 of HCV isolate H77. The reactivity of the serum in the enzyme-linked immunosorbent assay was correlated with the 13 amino acids (position 398-410) in HVR1. The serum prevented infection with H77 virus in cell cultures but did not prevent infection with H90 virus, a genetically divergent isolate from the same patient. The study demonstrated that neutralization of HCV was mediated, in part, by isolate-specific antibody recognizing HVR1. ᭧
Hepatitis virus C (HCV) infection is a worldwide health
taining antibodies to a synthetic peptide with the seproblem. It persists in over 80% of infected cases and quence of a specific HVR1 neutralizes a strain of HCV may result in chronic hepatitis, liver cirrhosis, and hepathat contains the same HVR 1 sequence. tocellular carcinoma. The development of an effective A peptide with 21 amino acids (peptide A in Fig. 1A ) vaccine would be the most efficient method to prevent was synthesized based on the published HVR1 sequence these diseases. However, HCV is known to undergo geof strain H77 (12), a pedigreed isolate of HCV, and counetic mutation during infection even within one individual pled with tetanus toxin at the N-terminus. Rabbit 87 re-(1-3). Hypervariable region 1 (HVR1), the N-terminal 27 ceived two immunizations at 1-month intervals intraamino acids within the putative envelope protein E2, dermically, using 500 mg of the conjugated peptide in comprises the most variable region of the HCV genome complete Freund's adjuvant, followed by a booster 6 (4, 5). The variation is assumed to be caused by random months later. Serum samples were obtained prior to mutation and selection of mutants capable of escaping (coded as 87P) and 6 months after injection (coded as from neutralizing antibodies produced in the patients. We 87I). Serum 87I was reactive in enzyme-linked immupreviously established in vitro systems for detection of noabsorbent assay (ELISA) against the homologous pep-HCV infectivity using the human lymphocyte cell lines, tide and the recombinant E1/E2 protein complex ex-HPBMa10.2 (6, 7) and Daudi cells (8), and demonstrated pressed by a vaccinia vector. In order to locate amino that anti-HCV antibody can be detected by blocking the acids which affect the reactivity of serum 87I, 4 additional adsorption of HCV virions to the HPBMa10-2 cells (9) peptides (B, C, D, and E in Fig. 1A ) were synthesized and and by the formation of antigen-antibody complexes tested by ELISA. Microtiter plates were coated overnight (10). The antibody was isolate-specific and the specificity at 4Њ with each peptide at a concentration of 5 mg/well changed over time (9) . Recently, Zibert et al. demonand then blocked for 2 days with phosphate-buffered strated, employing the adsorption-blocking method, that saline containing 0.2% bovine serum albumin and 1% the majority of neutralizing antibodies in the patient sera Tween-20 (Sigma). The plates were incubated with serial were directed against the HVR1 of HCV (11). The study dilutions of serum 87P or serum 87I overnight at 4Њ, presented here examines whether immune serum conwashed, and incubated with peroxidase-labeled anti-rabbit IgG (MBL, Japan) for 2 hr at 37Њ. Enzyme reactions with substrates were carried out according to the standard tion of buoyant density (10). H90 has been shown to be positive for anti-HCV C22 and C100 antibodies by ELISA (9). Both have been shown to be infectious in chimpanzees; plasma H77 contained 10 6.5 50% chimpanzee infectious doses of HCV per milliliter (13) and 1 ml of undiluted plasma H90 was infectious in a chimpanzee (unpublished data).
To determine the adsorption efficiency of the H77 and H90 viruses to the cells, plasmas H77 and H90 were serially diluted in 10-fold increments and 100 ml of each dilution was inoculated into 1 ml of a suspension of 5 1 10 5 HPBMa10.2 cells. After incubation for 2 hr at 37Њ, the cells were washed twice and tested for cell-adsorbed HCV RNA by reverse transcription (RT)/PCR using nested primers which detect the E1/E2 region of the HCV genome. Plasmas H77 and H90 had genome titers of 10 6 / 100 and 10 5 /100 ml, respectively, by end-point dilution RT/PCR assay, but the adsorption titer was 10 3 /100 ml for H77 and 10 1 /100 ml for H90 ( Fig. 2A ). We also checked the HVR1 sequences of HCV adsorbed by the cells, since a high level of genetic diversity has been reported for H77 (14, 15) . The HCV genomes adsorbed by the cells at the dilutions of 10 03 for H77 and 10 01 for H90 were RT/PCR-amplified and the products were cloned into pUC118 (Takara, Japan) and 10-12 subclones were sequenced by ABI 373A sequencer with the Taq dye terminator cycle sequencing kit (Perkin-Elmer). For H77, 5 of 12 clones had the HVR 1 amino acid sequence which was the same as peptide A used for immunization except in Fig. 1B , immune serum 87 I was reactive with homologous peptide A and chimeric peptide D (amino-terminal H90 and carboxy-terminal H77) but not with peptide B (derived from the sequence of H90) or chimeric peptide C (amino-terminal H77 and carboxy-terminal H90). The substitution of three amino acids (positions 395-397), which were TTA in H77 and SVL in H90, appeared not to affect the reactivity of the peptide with serum 87I, suggesting that the 13 amino acids in positions 398-410 determined the reactivity. This was confirmed by the positive reaction of serum 87I with peptide E, consisting primarily of these amino acids (Fig. 1B) .
FIG. 2. (A) Adsorption compared with titers of the HCV genome in
In the neutralization test, isolate H77, representing the inocula. The detection of HCV RNA by RT/PCR was performed using nested primers that amplify the E1/E2 region (nucleotide positions HCV in the acute-phase plasma, and isolate H90, a ge-1437-1709) of the HCV genome. (B) Genetic variation in the HVR1 netically divergent isolate in a chronic-phase plasma ob-(between residues 390 and 410) of the cell-adsorbed HCV after expotained 13 years after infection from the same patient (12), sure to dilutions of 10 03 for H77 and 10 01 for H90. Number of clones were used as target viruses. H77 has been shown to be with individual sequences among 12 sequences for H77 and among negative for antibodies to HCV by ELISA, immunoprecipi-for one amino acid at position 391 and 7 of 12 clones retained the sequence common to peptides A, D, and E, which reacted with the 87I serum. For H90, 5 of the 10 clones had the same sequence as peptide B (Fig. 2B) .
To determine whether serum 87I blocks the binding of HCV to the cells, we examined it in HPBMa10-2 cells as we reported previously (9). Daudi cells were not employed for the adsorption inhibition assay since it was found that virus-antibody complexes could be adsorbed by Daudi cells, a lineage of B cells, probably through the Fc receptor. A 100-ml sample of each target virus (at a 10 03 dilution for H77 and a 10 01 dilution for H90, which corresponded to one adsorption titer per milliliter; see above) was incubated overnight at 4Њ with an equal volume of a 1:10 dilution of serum 87P or serum 87I previously heated at 56Њ for 30 min, inoculated into 1 ml of a suspension containing 5 1 10 5 HPBMa10.2 cells, and incubated for 2 hr at 37Њ. After washing, the cell-adsorbed HCV RNA was assayed by RT/PCR. As shown in Fig. 3A , serum 87I inhibited the binding of H77 to the cells (Exp. 1 and Exp. 2 in Fig. 3A) . However, in one experiment among three trials (Exp. 3 in Fig. 3A) , celladsorbed HCV RNA was detected following incubation of H77 with serum 87I. This was probably due to the sequence heterogenity of the inoculum used (see above). Serum 87I did not inhibit the binding of H90 to the cells in any of the three trials.
To further investigate whether the adsorption inhibition by serum 87I mentioned above was correlated with the inhibition of viral replication, we performed neutralization experiments in HPBMa10.2 cells and Daudi cells, whose culture was continued for 12 days after adsorption to H90 and serum 87P or 87I using HPBMa10-2 cells. Three independent Treatment of the target viruses with serum 87P or serum experiments (Exp. 1, Exp. 2, and Exp. 3) were carried out as described in the text. The cell-adsorbed HCV was detected by RT/PCR using 87I and inoculation into the cells were carried out in nested primers detecting the E1/E2 region of the HCV genome. (B) the same manner as described above for the binding-Neutralization assays with HCV strains H77 or H90 and serum 87P or inhibition assay. Here the concentration of the target vi-87I in cell culture. Neutralization test was performed in HPBMa10-2 ruses was twofold higher than that for the adsorption cells and Daudi cells as described in the text. The residual infectivity inhibition. The presence of HCV RNA in the cells was of the virus was evaluated by the detection of intracellular HCV RNA by RT/PCR using nested primers detecting the E1/E2 region of the examined by RT/PCR at intervals and the products were genome. (C) Amino acid sequences of the HVR 1 recovered from the subjected to direct sequencing. Figure 3B cultures. When neutralization was attempted with the H90 virus, both serum 87P and serum 87I failed to prevent infection in both cultures. Thus, neutralization by as the sequence representing a major population in the H77 inoculum (15). Similar results were obtained with serum 87I appeared to be isolate-specific. The cell cultures were sometimes intermittently positive during the Day 0 and Day 12 harvests of Daudi cells. At the nucleotide level, however, the sequence recovered on Day 0 course of infection, but such intermittent positivity was characteristic of HCV-carrier cultures (7) . and the sequence recovered on Day 9 from HPBMa10-2 cells or on Day 12 from Daudi cells differed by one We also examined the sequences of HCV strains recovered from the neutralization experiments. When nucleotide at position 1517: C for Day 0 and T for Days 9 and 12 (asterisks in Fig. 3C indicate A (alanine) en-HPBMa10.2 cells were incubated with H77 treated with preimmune serum 87P, the amino acid sequence recov-coded by GCT instead of GCC). The sequence with T at position 1517 was a minority at adsorption, but this ered from cells harvested on Days 0 and 9 was the same sequence was the one that persisted as a selected vari-ACKNOWLEDGMENTS ant during long-term culture of H77 in HPBMa10-2 and This work was supported, in part, by a grant from the Viral Hepatitis
